Orthofix Announces Changes to Board of Directors
20 Junho 2023 - 5:01PM
Business Wire
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and
orthopedics company, today announced that Catherine Burzik has been
re-appointed as the Chair of the Company’s Board of Directors.
Additionally, shareholders re-elected Wayne Burris who previously
served on the Orthofix board from 2021-2022. Burris will serve on
the Audit and Finance and Compliance and Ethics Committees. As
previously announced Jon Serbousek, who served as Executive
Chairman of the Board, did not stand for re-election at the annual
shareholders meeting held yesterday.
Burzik previously served as the Company’s Chair of the Board
from 2021-2022 before assuming the position of Lead Independent
Director of the new combined board that was formed following the
merger of SeaSpine and Orthofix.
“I am honored to step back into the role of Chair for Orthofix,”
said Catherine Burzik. “I would like to thank Jon for his
leadership and commitment to the company and the merger
integration. I am grateful for the counsel he provided as both the
Chief Executive Officer of Orthofix and as the Executive Chairman
of the board and we wish him the best as he continues his work to
advance the medical device industry.” Burzik continued, “I am also
pleased to welcome back Wayne Burris whose dedication and strong
background in accounting and finance will help guide us to
long-term success.”
“I am delighted to rejoin the Orthofix Board of Directors,” said
Wayne Burris. “I look forward to working with Keith Valentine and
his leadership team to drive collaboration as the new merged
company strives to be the partner of choice for our surgeon
customers.”
Prior to joining the Orthofix Board of Directors, Burzik served
as President and Chief Executive Officer of Kinetic Concepts, Inc.,
a global medical device company, from 2006 until the company’s sale
in 2011. Prior to that, she served as President of Applied
Biosystems Group and held senior executive positions at Eastman
Kodak Health Imaging Systems and President of Ortho-Clinical
Diagnostics, Inc., a Johnson & Johnson company.
Burris served as the Senior Vice President and Chief Financial
Officer (CFO) at Roche Diagnostics Corporation from 1996 through
his retirement in July 2019. A member of the Global Roche
Diagnostics Finance Executive Committee, Burris was recognized as
one of their top senior leaders.
About Orthofix
The newly merged Orthofix-SeaSpine organization is a leading
global spine and orthopedics company with a comprehensive portfolio
of biologics, innovative spinal hardware, bone growth therapies,
specialized orthopedic solutions and a leading surgical navigation
system. Its products are distributed in more than 68 countries
worldwide.
The Company is headquartered in Lewisville, Texas and has
primary offices in Carlsbad, CA, with a focus on spine and
biologics product innovation and surgeon education, and Verona,
Italy, with an emphasis on product innovation, production, and
medical education for orthopedics. The combined company’s global
R&D, commercial and manufacturing footprint also includes
facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale,
CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany,
Paris, France, and São Paulo, Brazil.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230620683845/en/
Media Relations Denise Landry DeniseLandry@orthofix.com
214.937.2529
Investor Relations Louisa Smith, Gilmartin Group
IR@orthofix.com
Orthofix Medical (NASDAQ:OFIX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Orthofix Medical (NASDAQ:OFIX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024